These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 12052140)
1. The role of genomics in the discovery of novel targets for antibiotic therapy. Ji Y Pharmacogenomics; 2002 May; 3(3):315-23. PubMed ID: 12052140 [TBL] [Abstract][Full Text] [Related]
2. Delivering novel targets and antibiotics from genomics. Payne DJ; Holmes DJ; Rosenberg M Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Using genomics to develop novel antibacterial therapeutics. Nagaraj NS; Singh OV Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176 [TBL] [Abstract][Full Text] [Related]
5. Use of genomics to select antibacterial targets. Pucci MJ Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986 [TBL] [Abstract][Full Text] [Related]
6. Antibacterial drug discovery--then, now and the genomics future. Monaghan RL; Barrett JF Biochem Pharmacol; 2006 Mar; 71(7):901-9. PubMed ID: 16494849 [TBL] [Abstract][Full Text] [Related]
7. Functional genomics in antibacterial drug discovery. Freiberg C; Brötz-Oesterhelt H Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812 [TBL] [Abstract][Full Text] [Related]
8. The impact of genomics on novel antibacterial targets. Payne DJ; Wallis NG; Gentry DR; Rosenberg M Curr Opin Drug Discov Devel; 2000 Mar; 3(2):177-90. PubMed ID: 19649849 [TBL] [Abstract][Full Text] [Related]
9. When will the genomics investment pay off for antibacterial discovery? Mills SD Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281 [TBL] [Abstract][Full Text] [Related]
10. Novel targets for the future development of antibacterial agents. McDevitt D; Payne DJ; Holmes DJ; Rosenberg M Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826 [TBL] [Abstract][Full Text] [Related]
11. The decline of antibiotic era--new approaches for antibacterial drug discovery. Jagusztyn-Krynicka EK; Wyszyńska A Pol J Microbiol; 2008; 57(2):91-8. PubMed ID: 18646395 [TBL] [Abstract][Full Text] [Related]
14. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets. Butt AM; Tahir S; Nasrullah I; Idrees M; Lu J; Tong Y Infect Genet Evol; 2012 Jan; 12(1):53-62. PubMed ID: 22057004 [TBL] [Abstract][Full Text] [Related]
15. Exploiting genomics, genetics and chemistry to combat antibiotic resistance. Hughes D Nat Rev Genet; 2003 Jun; 4(6):432-41. PubMed ID: 12776213 [TBL] [Abstract][Full Text] [Related]
16. DNA microarray technology and antimicrobial drug discovery. Ivanov I; Schaab C; Planitzer S; Teichmann U; Machl A; Theml S; Meier-Ewert S; Seizinger B; Loferer H Pharmacogenomics; 2000 May; 1(2):169-78. PubMed ID: 11256588 [TBL] [Abstract][Full Text] [Related]
17. New screens and targets in antibacterial drug discovery. Falconer SB; Brown ED Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance in bacteria and its future for novel antibiotic development. Yoneyama H; Katsumata R Biosci Biotechnol Biochem; 2006 May; 70(5):1060-75. PubMed ID: 16717405 [TBL] [Abstract][Full Text] [Related]
19. A bioinformatic approach to understanding antibiotic resistance in intracellular bacteria through whole genome analysis. Biswas S; Raoult D; Rolain JM Int J Antimicrob Agents; 2008 Sep; 32(3):207-20. PubMed ID: 18619818 [TBL] [Abstract][Full Text] [Related]